Identification of amino acid residues of 5-lipoxygenase-activating protein essential for the binding of leukotriene biosynthesis inhibitors
5-Lipoxygenase-activating protein (FLAP) is specifically labeled by [125I]L-669,083 and [125I]L-691,678, photoaffinity analogues of two classes of potent leukotriene biosynthesis inhibitors. Because human FLAP contains only a single tryptophan residue at position 72 and two internal methionine resid...
Gespeichert in:
Veröffentlicht in: | Molecular pharmacology 1992-07, Vol.42 (1), p.94-102 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 102 |
---|---|
container_issue | 1 |
container_start_page | 94 |
container_title | Molecular pharmacology |
container_volume | 42 |
creator | VICKERS, P. J ADAM, M CHARLESON, S COPPOLINO, M. G EVANS, J. F MANCINI, J. A |
description | 5-Lipoxygenase-activating protein (FLAP) is specifically labeled by [125I]L-669,083 and [125I]L-691,678, photoaffinity analogues
of two classes of potent leukotriene biosynthesis inhibitors. Because human FLAP contains only a single tryptophan residue
at position 72 and two internal methionine residues at positions 89 and 125, we have used reagents that specifically cleave
at these residues, in conjunction with antipeptide antisera, to localize the site of attachment of the photoaffinity ligands.
Immunoprecipitation of specifically labeled peptide fragments after digestion of photoaffinity-labeled FLAP by iodosobenzoic
acid at 72Trp demonstrates that the inhibitors bind to FLAP amino-terminal to this residue. This finding is consistent with
similar immunoprecipitation studies after digestion at methionine residues using cyanogen bromide. These findings localize
the site of attachment of the inhibitors to a region of FLAP that includes the hydrophilic loop between the proposed first
and second transmembrane regions. Based on these findings, site-directed mutagenesis of human FLAP was performed to define
key amino acids involved in inhibitor binding. Using a radioligand binding assay, analysis of mutants of human FLAP expressed
in COS-7 cells demonstrates that a number of residues in the amino-terminal half of the first hydrophilic loop of the protein
can be deleted without significantly affecting inhibitor binding. In contrast, no inhibitor binding was detectable with mutants
in which amino acid residues in the carboxyl-terminal half of this loop were deleted. Furthermore, a point mutation of 62Asp
to asparagine results in a mutant with dramatically reduced affinity for inhibitors. This loss of affinity was not displayed
by a mutant in which 62Asp was mutated to a glutamate residue, suggesting that a negative charge associated with residue 62
may be critical for inhibitor binding. The roles that amino acid residues in the carboxyl-terminal half of the first hydrophilic
loop of FLAP may play in the binding of leukotriene biosynthesis inhibitors are currently under investigation. |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_16336078</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16336078</sourcerecordid><originalsourceid>FETCH-LOGICAL-h295t-ca9afc59afa8a4c91e456fd544fc3d6f610bf141f3e0d5437042ea6e66cba1123</originalsourceid><addsrcrecordid>eNpFkN1KJDEQhRtZ0fHnERZyIXvXkHR-ZvpyEXdXELxR8K6pTlemS7uTMcmszjP40pvBwb2pglPfOVTVUbUQuhE1F0J8qxacN6ZetfrptDpL6ZlzofSKn1QnwkittVlUH7cD-kyOLGQKngXHYCYfGFgaWMREwxbTXtb1RJvwvlujh4Q12Ex_i8ev2SaGjOQZprTPgom5EFkekfXkhz1R7BNuX0KOhH4vh7TzBUiUGPmResohpovq2MGU8PLQz6vHXzcP13_qu_vft9c_7-qxaXWuLbTgrC4FVqBsK1Bp4watlLNyMM4I3juhhJPIiyqXXDUIBo2xPQjRyPPqx2duWfy1XJe7mZLFaQKPYZu68hxp-HJVwO8HcNvPOHSbSDPEXXf4XplfHeaQLEwugreUvjCtl1K2y__YSOvxjSJ2mxHiDDZMYb3rVNOJrlXyH_Swimw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16336078</pqid></control><display><type>article</type><title>Identification of amino acid residues of 5-lipoxygenase-activating protein essential for the binding of leukotriene biosynthesis inhibitors</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>VICKERS, P. J ; ADAM, M ; CHARLESON, S ; COPPOLINO, M. G ; EVANS, J. F ; MANCINI, J. A</creator><creatorcontrib>VICKERS, P. J ; ADAM, M ; CHARLESON, S ; COPPOLINO, M. G ; EVANS, J. F ; MANCINI, J. A</creatorcontrib><description>5-Lipoxygenase-activating protein (FLAP) is specifically labeled by [125I]L-669,083 and [125I]L-691,678, photoaffinity analogues
of two classes of potent leukotriene biosynthesis inhibitors. Because human FLAP contains only a single tryptophan residue
at position 72 and two internal methionine residues at positions 89 and 125, we have used reagents that specifically cleave
at these residues, in conjunction with antipeptide antisera, to localize the site of attachment of the photoaffinity ligands.
Immunoprecipitation of specifically labeled peptide fragments after digestion of photoaffinity-labeled FLAP by iodosobenzoic
acid at 72Trp demonstrates that the inhibitors bind to FLAP amino-terminal to this residue. This finding is consistent with
similar immunoprecipitation studies after digestion at methionine residues using cyanogen bromide. These findings localize
the site of attachment of the inhibitors to a region of FLAP that includes the hydrophilic loop between the proposed first
and second transmembrane regions. Based on these findings, site-directed mutagenesis of human FLAP was performed to define
key amino acids involved in inhibitor binding. Using a radioligand binding assay, analysis of mutants of human FLAP expressed
in COS-7 cells demonstrates that a number of residues in the amino-terminal half of the first hydrophilic loop of the protein
can be deleted without significantly affecting inhibitor binding. In contrast, no inhibitor binding was detectable with mutants
in which amino acid residues in the carboxyl-terminal half of this loop were deleted. Furthermore, a point mutation of 62Asp
to asparagine results in a mutant with dramatically reduced affinity for inhibitors. This loss of affinity was not displayed
by a mutant in which 62Asp was mutated to a glutamate residue, suggesting that a negative charge associated with residue 62
may be critical for inhibitor binding. The roles that amino acid residues in the carboxyl-terminal half of the first hydrophilic
loop of FLAP may play in the binding of leukotriene biosynthesis inhibitors are currently under investigation.</description><identifier>ISSN: 0026-895X</identifier><identifier>EISSN: 1521-0111</identifier><identifier>PMID: 1635556</identifier><identifier>CODEN: MOPMA3</identifier><language>eng</language><publisher>Bethesda, MD: American Society for Pharmacology and Experimental Therapeutics</publisher><subject>5-lipoxygenase-activating protein ; 5-Lipoxygenase-Activating Proteins ; Affinity Labels ; Amino Acid Sequence ; amino acids ; Amino Acids - metabolism ; Analytical, structural and metabolic biochemistry ; Azides - metabolism ; binding ; Binding, Competitive ; Biological and medical sciences ; Blotting, Western ; Carrier Proteins - genetics ; Carrier Proteins - metabolism ; Cell Line ; Fatty acids ; Fundamental and applied biological sciences. Psychology ; Genetic Vectors ; Humans ; identification ; Indoles - metabolism ; inhibitors ; leukotriene ; Leukotrienes - biosynthesis ; Lipids ; Membrane Proteins - genetics ; Membrane Proteins - metabolism ; Molecular Sequence Data ; Mutagenesis, Site-Directed ; Other biological molecules ; Precipitin Tests ; Quinolines - metabolism ; Radioligand Assay ; site-directed mutagenesis ; synthesis</subject><ispartof>Molecular pharmacology, 1992-07, Vol.42 (1), p.94-102</ispartof><rights>1992 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=5573397$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1635556$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>VICKERS, P. J</creatorcontrib><creatorcontrib>ADAM, M</creatorcontrib><creatorcontrib>CHARLESON, S</creatorcontrib><creatorcontrib>COPPOLINO, M. G</creatorcontrib><creatorcontrib>EVANS, J. F</creatorcontrib><creatorcontrib>MANCINI, J. A</creatorcontrib><title>Identification of amino acid residues of 5-lipoxygenase-activating protein essential for the binding of leukotriene biosynthesis inhibitors</title><title>Molecular pharmacology</title><addtitle>Mol Pharmacol</addtitle><description>5-Lipoxygenase-activating protein (FLAP) is specifically labeled by [125I]L-669,083 and [125I]L-691,678, photoaffinity analogues
of two classes of potent leukotriene biosynthesis inhibitors. Because human FLAP contains only a single tryptophan residue
at position 72 and two internal methionine residues at positions 89 and 125, we have used reagents that specifically cleave
at these residues, in conjunction with antipeptide antisera, to localize the site of attachment of the photoaffinity ligands.
Immunoprecipitation of specifically labeled peptide fragments after digestion of photoaffinity-labeled FLAP by iodosobenzoic
acid at 72Trp demonstrates that the inhibitors bind to FLAP amino-terminal to this residue. This finding is consistent with
similar immunoprecipitation studies after digestion at methionine residues using cyanogen bromide. These findings localize
the site of attachment of the inhibitors to a region of FLAP that includes the hydrophilic loop between the proposed first
and second transmembrane regions. Based on these findings, site-directed mutagenesis of human FLAP was performed to define
key amino acids involved in inhibitor binding. Using a radioligand binding assay, analysis of mutants of human FLAP expressed
in COS-7 cells demonstrates that a number of residues in the amino-terminal half of the first hydrophilic loop of the protein
can be deleted without significantly affecting inhibitor binding. In contrast, no inhibitor binding was detectable with mutants
in which amino acid residues in the carboxyl-terminal half of this loop were deleted. Furthermore, a point mutation of 62Asp
to asparagine results in a mutant with dramatically reduced affinity for inhibitors. This loss of affinity was not displayed
by a mutant in which 62Asp was mutated to a glutamate residue, suggesting that a negative charge associated with residue 62
may be critical for inhibitor binding. The roles that amino acid residues in the carboxyl-terminal half of the first hydrophilic
loop of FLAP may play in the binding of leukotriene biosynthesis inhibitors are currently under investigation.</description><subject>5-lipoxygenase-activating protein</subject><subject>5-Lipoxygenase-Activating Proteins</subject><subject>Affinity Labels</subject><subject>Amino Acid Sequence</subject><subject>amino acids</subject><subject>Amino Acids - metabolism</subject><subject>Analytical, structural and metabolic biochemistry</subject><subject>Azides - metabolism</subject><subject>binding</subject><subject>Binding, Competitive</subject><subject>Biological and medical sciences</subject><subject>Blotting, Western</subject><subject>Carrier Proteins - genetics</subject><subject>Carrier Proteins - metabolism</subject><subject>Cell Line</subject><subject>Fatty acids</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Genetic Vectors</subject><subject>Humans</subject><subject>identification</subject><subject>Indoles - metabolism</subject><subject>inhibitors</subject><subject>leukotriene</subject><subject>Leukotrienes - biosynthesis</subject><subject>Lipids</subject><subject>Membrane Proteins - genetics</subject><subject>Membrane Proteins - metabolism</subject><subject>Molecular Sequence Data</subject><subject>Mutagenesis, Site-Directed</subject><subject>Other biological molecules</subject><subject>Precipitin Tests</subject><subject>Quinolines - metabolism</subject><subject>Radioligand Assay</subject><subject>site-directed mutagenesis</subject><subject>synthesis</subject><issn>0026-895X</issn><issn>1521-0111</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkN1KJDEQhRtZ0fHnERZyIXvXkHR-ZvpyEXdXELxR8K6pTlemS7uTMcmszjP40pvBwb2pglPfOVTVUbUQuhE1F0J8qxacN6ZetfrptDpL6ZlzofSKn1QnwkittVlUH7cD-kyOLGQKngXHYCYfGFgaWMREwxbTXtb1RJvwvlujh4Q12Ex_i8ev2SaGjOQZprTPgom5EFkekfXkhz1R7BNuX0KOhH4vh7TzBUiUGPmResohpovq2MGU8PLQz6vHXzcP13_qu_vft9c_7-qxaXWuLbTgrC4FVqBsK1Bp4watlLNyMM4I3juhhJPIiyqXXDUIBo2xPQjRyPPqx2duWfy1XJe7mZLFaQKPYZu68hxp-HJVwO8HcNvPOHSbSDPEXXf4XplfHeaQLEwugreUvjCtl1K2y__YSOvxjSJ2mxHiDDZMYb3rVNOJrlXyH_Swimw</recordid><startdate>19920701</startdate><enddate>19920701</enddate><creator>VICKERS, P. J</creator><creator>ADAM, M</creator><creator>CHARLESON, S</creator><creator>COPPOLINO, M. G</creator><creator>EVANS, J. F</creator><creator>MANCINI, J. A</creator><general>American Society for Pharmacology and Experimental Therapeutics</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7QL</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>M81</scope><scope>P64</scope></search><sort><creationdate>19920701</creationdate><title>Identification of amino acid residues of 5-lipoxygenase-activating protein essential for the binding of leukotriene biosynthesis inhibitors</title><author>VICKERS, P. J ; ADAM, M ; CHARLESON, S ; COPPOLINO, M. G ; EVANS, J. F ; MANCINI, J. A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h295t-ca9afc59afa8a4c91e456fd544fc3d6f610bf141f3e0d5437042ea6e66cba1123</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>5-lipoxygenase-activating protein</topic><topic>5-Lipoxygenase-Activating Proteins</topic><topic>Affinity Labels</topic><topic>Amino Acid Sequence</topic><topic>amino acids</topic><topic>Amino Acids - metabolism</topic><topic>Analytical, structural and metabolic biochemistry</topic><topic>Azides - metabolism</topic><topic>binding</topic><topic>Binding, Competitive</topic><topic>Biological and medical sciences</topic><topic>Blotting, Western</topic><topic>Carrier Proteins - genetics</topic><topic>Carrier Proteins - metabolism</topic><topic>Cell Line</topic><topic>Fatty acids</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Genetic Vectors</topic><topic>Humans</topic><topic>identification</topic><topic>Indoles - metabolism</topic><topic>inhibitors</topic><topic>leukotriene</topic><topic>Leukotrienes - biosynthesis</topic><topic>Lipids</topic><topic>Membrane Proteins - genetics</topic><topic>Membrane Proteins - metabolism</topic><topic>Molecular Sequence Data</topic><topic>Mutagenesis, Site-Directed</topic><topic>Other biological molecules</topic><topic>Precipitin Tests</topic><topic>Quinolines - metabolism</topic><topic>Radioligand Assay</topic><topic>site-directed mutagenesis</topic><topic>synthesis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>VICKERS, P. J</creatorcontrib><creatorcontrib>ADAM, M</creatorcontrib><creatorcontrib>CHARLESON, S</creatorcontrib><creatorcontrib>COPPOLINO, M. G</creatorcontrib><creatorcontrib>EVANS, J. F</creatorcontrib><creatorcontrib>MANCINI, J. A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biochemistry Abstracts 3</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Molecular pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>VICKERS, P. J</au><au>ADAM, M</au><au>CHARLESON, S</au><au>COPPOLINO, M. G</au><au>EVANS, J. F</au><au>MANCINI, J. A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Identification of amino acid residues of 5-lipoxygenase-activating protein essential for the binding of leukotriene biosynthesis inhibitors</atitle><jtitle>Molecular pharmacology</jtitle><addtitle>Mol Pharmacol</addtitle><date>1992-07-01</date><risdate>1992</risdate><volume>42</volume><issue>1</issue><spage>94</spage><epage>102</epage><pages>94-102</pages><issn>0026-895X</issn><eissn>1521-0111</eissn><coden>MOPMA3</coden><abstract>5-Lipoxygenase-activating protein (FLAP) is specifically labeled by [125I]L-669,083 and [125I]L-691,678, photoaffinity analogues
of two classes of potent leukotriene biosynthesis inhibitors. Because human FLAP contains only a single tryptophan residue
at position 72 and two internal methionine residues at positions 89 and 125, we have used reagents that specifically cleave
at these residues, in conjunction with antipeptide antisera, to localize the site of attachment of the photoaffinity ligands.
Immunoprecipitation of specifically labeled peptide fragments after digestion of photoaffinity-labeled FLAP by iodosobenzoic
acid at 72Trp demonstrates that the inhibitors bind to FLAP amino-terminal to this residue. This finding is consistent with
similar immunoprecipitation studies after digestion at methionine residues using cyanogen bromide. These findings localize
the site of attachment of the inhibitors to a region of FLAP that includes the hydrophilic loop between the proposed first
and second transmembrane regions. Based on these findings, site-directed mutagenesis of human FLAP was performed to define
key amino acids involved in inhibitor binding. Using a radioligand binding assay, analysis of mutants of human FLAP expressed
in COS-7 cells demonstrates that a number of residues in the amino-terminal half of the first hydrophilic loop of the protein
can be deleted without significantly affecting inhibitor binding. In contrast, no inhibitor binding was detectable with mutants
in which amino acid residues in the carboxyl-terminal half of this loop were deleted. Furthermore, a point mutation of 62Asp
to asparagine results in a mutant with dramatically reduced affinity for inhibitors. This loss of affinity was not displayed
by a mutant in which 62Asp was mutated to a glutamate residue, suggesting that a negative charge associated with residue 62
may be critical for inhibitor binding. The roles that amino acid residues in the carboxyl-terminal half of the first hydrophilic
loop of FLAP may play in the binding of leukotriene biosynthesis inhibitors are currently under investigation.</abstract><cop>Bethesda, MD</cop><pub>American Society for Pharmacology and Experimental Therapeutics</pub><pmid>1635556</pmid><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0026-895X |
ispartof | Molecular pharmacology, 1992-07, Vol.42 (1), p.94-102 |
issn | 0026-895X 1521-0111 |
language | eng |
recordid | cdi_proquest_miscellaneous_16336078 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | 5-lipoxygenase-activating protein 5-Lipoxygenase-Activating Proteins Affinity Labels Amino Acid Sequence amino acids Amino Acids - metabolism Analytical, structural and metabolic biochemistry Azides - metabolism binding Binding, Competitive Biological and medical sciences Blotting, Western Carrier Proteins - genetics Carrier Proteins - metabolism Cell Line Fatty acids Fundamental and applied biological sciences. Psychology Genetic Vectors Humans identification Indoles - metabolism inhibitors leukotriene Leukotrienes - biosynthesis Lipids Membrane Proteins - genetics Membrane Proteins - metabolism Molecular Sequence Data Mutagenesis, Site-Directed Other biological molecules Precipitin Tests Quinolines - metabolism Radioligand Assay site-directed mutagenesis synthesis |
title | Identification of amino acid residues of 5-lipoxygenase-activating protein essential for the binding of leukotriene biosynthesis inhibitors |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T03%3A41%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Identification%20of%20amino%20acid%20residues%20of%205-lipoxygenase-activating%20protein%20essential%20for%20the%20binding%20of%20leukotriene%20biosynthesis%20inhibitors&rft.jtitle=Molecular%20pharmacology&rft.au=VICKERS,%20P.%20J&rft.date=1992-07-01&rft.volume=42&rft.issue=1&rft.spage=94&rft.epage=102&rft.pages=94-102&rft.issn=0026-895X&rft.eissn=1521-0111&rft.coden=MOPMA3&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E16336078%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16336078&rft_id=info:pmid/1635556&rfr_iscdi=true |